MitchellEricHorwitzMD

PubMed

• High risk of acute pulmonary toxicity with both myeloablative and non-myeloablative total body irradiation-based conditioning for allogeneic stem cell transplantation.
  Pranalee Patel, Mairead Dillon, Donna Niedzwiecki, Kerri-Anne Crowell, Mitchell E Horwitz, Edina Wang, Chris R Kelsey> ;Bone Marrow Transplantation. 2024 Jan 1
• Blood stem cell grafts: frozen is fine, but fresh is best.
  Mitchell E Horwitz> ;Blood Advances. 2023 Oct 10
• 2 citations
  Corrigendum to 'Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials'.
  Chenyu Lin, Mitchell E Horwitz> ;Transplantation and Cellular Therapy. 2023 Jul 5
• 7 citations
  A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
  Chenyu Lin, Rachel A DiCioccio, Tarek Haykal, William C McManigle, Zhiguo Li, Sarah M Anand, Jonathan C Poe, Sonali J Bracken, Wei Jia, Edwin P Alyea 3rd, Adela R Card...> ;Transplantation and Cellular Therapy. 2023 Mar 1
• 5 citations
  Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
  Rezvani, A. R., Chenyu Lin, Gautam Sajeev, Patrick J Stiff, Claudio G Brunstein, Corey Cutler, Guillermo Sanz, Caroline A Lindemans, Andrew R Rezvani, Rabi Hanna, Lian...> ;Transplantation and Cellular Therapy. 2023 Jan 1
• Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond.
  Chenyu Lin, Mitchell E Horwitz, Lindsay A M Rein> ;International Journal of Molecular Sciences. 2022 Dec 22
• Optimizing Management of the Central Nervous System in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplantation.
  Mairead Dillon, Donna Niedzwiecki, Mitchell E Horwitz, Chris R Kelsey, Patel, P.> ;Advances in Radiation Oncology. 2022 Dec 10
• 1 citations
  Revisiting a single day salvage conditioning following graft failure.
  Emmanuel Katsanis, Therese Hennig, Jacob E Robinson, Gwynn Long, Nelson Chao, Mitchell Horwitz, David Rizzieri> ;Bone Marrow Transplantation. 2022 Dec 1
• 16 citations
  Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase ...
  Amy E DeZern, Mary Eapen, Juan Wu, Julie-An Talano, Melhem Solh, Blachy J Dávila Saldaña, Chatchada Karanes, Mitchell E Horwitz, Kanwaldeep Mallhi, Sally Arai, Nosha F...> ;The Lancet. Haematology. 2022 Sep 1
• 4 citations
  Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.
  Meagan V Lew, Yi Ren, Yen P Lowder, Sharareh Siamakpour-Reihani, Sendhilnathan Ramalingam, Kristi M Romero, Jillian C Thompson, Lauren M Bohannon, Jackie McIntyre, Hel...> ;Transplantation and Cellular Therapy. 2022 Aug 1
• The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis.
  Heather R Wolfe, Mitchell E Horwitz, Lindsay A M Rein> ;Journal of Personalized Medicine. 2022 Apr 2
• 3 citations
  Home-Based Hematopoietic Cell Transplantation in the United States.
  Anthony D Sung, Vinay K Giri, Helen Tang, Krista Rowe Nichols, Meagan V Lew, Lauren Bohannon, Yi Ren, Sin-Ho Jung, Tara Dalton, Amy Bush, Jolien Van Opstal, Alexandra ...> ;Transplantation and Cellular Therapy. 2022 Apr 1
• 2 citations
  Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.
  Patrick Smith, Meagan Lew, Yen P. Lowder, Kristi Romero, Jillian C. Thompson, Lauren Bohannon, Alyssa Pittman, Alexandra Artica, Sendhilnathan Ramalingam, Taewoong Cho...> ;Bone Marrow Transplantation. 2021 Oct 19
• 20 citations
  Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
  Alex F. Herrera, Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Qaiser Bashir, Ruthee-Lu Bayer, Melanie Coleman, Zachariah DeFilipp, Nosha Farhadfar, Matthew Gr...> ;Blood Advances. 2021 Sep 28
• 5 citations
  Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation
  Coco de Koning, Weiyang Tao, Amelia M. Lacna, Karin van Veghel, Mitchell E. Horwitz, Guillermo Sanz, Madan Jagasia, John E. Wagner, Patrick J. Stiff, Rabi Hanna, Danie...> ;Bone Marrow Transplantation. 2021 Jul 26
• 7 citations
  Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation.
  Doris M. Ponce, Ioannis Politikos, Amin M. Alousi, Paul A. Carpenter, Filippo Milano, Margaret L. MacMillan, Juliet N. Barker, Mitchell E. Horwitz> ;Transplantation and Cellular Therapy. 2021 Jul 1
• 2 citations
  A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
  Sendhilnathan Ramalingam, Sharareh Siamakpour-Reihani, Lauren Bohannan, Yi Ren, Alexander B. Sibley, Jeff Sheng, Li Ma, Andrew B. Nixon, Jing Lyu, Daniel C. Parker, Ja...> ;Plos One. 2021 Jun 25
• 38 citations
  Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
  Mitchell E. Horwitz, Patrick J. Stiff, Corey Cutler, Claudio G. Brunstein, Rabi Hanna, Richard T. Maziarz, Andrew R. Rezvani, Nicole A. Karris, Joseph P. McGuirk, Davi...> ;Blood. 2021 Oct 21
• 5 citations
  Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation
  Prioty Islam, Helen Tang, Haesu Jin, Lauren Bohannon, Yi Ren, Nelson J. Chao, Taewoong Choi, Cristina Gasparetto, Mitchell E. Horwitz, Gwynn D. Long, Richard D. Lopez,...> ;Transplantation and Cellular Therapy. 2021 Sep 1
• 2 citations
  Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.
  Cindy M. Pabon, Zhiguo Li, Therese Hennig, Carlos M. de Castro, Jadee L. Neff, Mitchell E. Horwitz, Thomas W. LeBlanc, Gwynn D. Long, Richard D. Lopez, Anthony D. Sung...> ;Blood Cancer Journal. 2021 May 16
• 3 citations
  Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malig...
  Lauren Bohannon, Helen Tang, Kristin Page, Yi Ren, Sin-Ho Jung, Alexandra Artica, Anne Britt, Prioty Islam, Sharareh Siamakpour-Reihani, Vinay K. Giri, Meagan Lew, Mat...> ;Transplantation and Cellular Therapy. 2021 May 12
• 48 citations
  Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow...
  Bart L. Scott, Marcelo C. Pasquini, Mingwei Fei, Raphael Fraser, Juan Wu, Steve Devine, David L. Porter, Richard T. Maziarz, Erica D. Warlick, Hugo F. Fernandez, Rober...> ;Transplantation and Cellular Therapy. 2021 Feb 26
• 12 citations
  Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients.
  Alessandro Racioppi, Tara Dalton, Sendhilnathan Ramalingam, Kristi Romero, Yi Ren, Lauren Bohannon, Consuelo Arellano, Jude Jonassaint, Hilary D. Miller, Ian Barak, La...> ;Transplantation and Cellular Therapy. 2021 Feb 1
• 15 citations
  Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome
  Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, Abel Licon, Edwin P. Alyea, Asad Bashey, Steven M. Devine, Hugo F. Fernandez, Sergio...> ;JCO Precision Oncology. 2021 Jan 25
• 59 citations
  Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.
  Ephraim J Fuchs, Paul V O'Donnell, Mary Eapen, Brent Logan, Joseph H Antin, Peter Dawson, Steven Devine, Mary M Horowitz, Mitchell E Horwitz, Chatchada Karanes, Eric L...> ;Blood. 2021 Jan 21
• Join now to see all

Journal Articles

• Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia  
  Barker JN, Fei M, Karanes C, Horwitz M, Devine S, Kindwall-Keller TL, Holter J, Adams A, Logan B, Navarro WH, Riches M; the RCI BMT 05-DCB Protocol Team, Br J Haematol, 1/1/2015
• Improving the Outcome of Umbilical Cord Blood Transplantation Through Ex Vivo Expansion or Graft Manipulation  
  Horwitz ME, Frassoni F, Cytotherapy, 1/1/2015
• Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1–2 dose de-escalation study  
  Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin J, Adams R, Arai S, Eames G, Horwitz M, McCarty J, Nakamura R, Pulsipher M, Rowley S, Leifer E, Carter S, DiFronz..., Lancet Haematology, 1/1/2015
• Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study  
  Kelsey CR, Scott JM, Lane A, Schwitzer E, West MJ, Thomas S, Herndon Ii JE, Michalski MG, Horwitz ME, Hennig T, Jones LW, Bone Marrow Transplant, 1/28/2014
• Increased BCR responsiveness in B cells from patients with chronic GVHD  
  Allen JL, Tata PV, Fore MS, Wooten J, Rudra S, Deal AM, Sharf A, Hoffert T, Roehrs PA, Shea TC, Serody JS, Richards KL, Jagasia M, Lee SJ, Rizzieri D, Horwitz ME, Chao..., Blood, 1/27/2014
• Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic mali...  
  Kanda J, Long GD, Gasparetto C, Horwitz ME, Sullivan KM, Chute JP, Morris A, Shafique M, Li Z, Chao NJ, Rizzieri DA, Biol Blood Marrow Transplant, 1/1/2014
• Umbilical Cord Blood Expansion with Nicotinamide Provides Long-term Multi-lineage Engraftment  
  Horwitz M, Chao N, Rizzieri D, Long G, Sullivan K, Gasparetto C, Chute J, Morris A, McDonald C, Waters-Pick B, Stiff P, Wease S, Peled A, Snyder D, Galamidi Cohen E, S..., J Clin Invest, 1/1/2014
• A phase I study of arsenic trioxide (trisenox), ascorbic Acid, and bortezomib (velcade) combination therapy in patients with relapsed/refractory multiple myeloma  
  Held LA, Rizzieri D, Long GD, Gockerman JP, Diehl LF, Castro CM, Moore JO, Horwitz ME, Chao NJ, Gasparetto C, Cancer Inves, 1/1/2013
• Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone  
  Sung AD, Grima DT, Bernard LM, Brown S, Carrum G, Holmberg L, Horwitz ME, Liesveld JL, Kanda J, McClune B, Shaughnessy P, Tricot GJ, Chao NJ, Bone Marrow Transplant, 1/1/2013
• Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation  
  Kanda J, Horwitz ME, Long GD, Gasparetto C, Sullivan KM, Chute JP, Morris A, Hennig T, Li Z, Chao NJ, Rizzieri DA, Bone Marrow Transplant, 1/1/2012
• Preemptive Dosing of Plerixafor Given To Poor Mobilizers on Day 5 of G-CSF Administration  
  Horwitz ME, Chute JP, Gasparetto C, Long G, McDonald C, Morris A, Rizzieri D, Sullivan K, Chao N, Bone Marrow Transplant, 1/1/2012
• Long-term Survival and Late Deaths After Hematopoietic Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism  
  Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, Hassebroek A, Ayas M, Bonfim C, O'Brien TA, Gross TG, Horwitz M, Horwitz E, Kapoor N, Kurtzberg J, Majhail N..., Biol Blood Marrow Transplant, 1/1/2012
• Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensi...  
  Chen DF, Prasad VK, Broadwater G, Reinsmoen NL, Deoliveira A, Clark A, Sullivan KM, Chute JP, Horwitz ME, Gasparetto C, Long GD, Yang Y, Chao NJ, Rizzieri DA, Biol Blood Marrow Transplant, 1/1/2012
• Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors  
  Horwitz ME, Long G, Holman P, Libby E, Calandra GC, Schriber JR, Bone Marrow Transplant, 1/1/2012
• Nakamura R, Pulsipher MA, Difronzo NL, Confer DL, Eapen M, Anderlini P Fludarabine-based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplas...  
  Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID, Carter SL, Horowitz MM, Biol Blood Marrow Transplant, 1/1/2012
• Immune Recovery in Adult Patients Following Myeloablative Dual Umbilical Cord Blood, Matched Sibling, and Matched Unrelated Donor Hematopoietic Cell Transplantation  
  Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, McPherson J, Hale J, Livingston JA, Broadwater G, Nie..., Biol Blood Marrow Transplant, 1/1/2012
• Mini test dose of intravenous busulfan (busulfex(R)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry  
  Spasojevic I, da Costa LR, Horwitz ME, Long GD, Sullivan KM, Chute JP, Gasparetto C, Morris A, Chao NJ, Rizzieri DA, Cancer Invest, 1/1/2012
• Clinical Outcomes following Hematopoietic Stem Cell Transplantation for the Treatment of Mucopolysaccharidosis VI  
  Turbeville S, Nicely H, Rizzo D, Pederson T, Orchard P, Horwitz M; Horwitz E, Veys P, Bonfim C, Al-Seraihy A, Molecular Genetics and Metabolism, 1/1/2011
• Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin ...  
  Palmer J, Goggins T, Broadwater G, Chao N, Horwitz M, Beaven A, Sullivan K, Coleman RE, Rizzieri D, Bone Marrow Transplant, 1/1/2011
• Reduced Intensity versus Myeloablative Allogeneic Stem Cell Transplantation for the Treatment of Acute Leukemia, Myelodysplastic Syndrome and Acute Lymphoid Leukemia  
  Horwitz ME, Curr Opin Oncol, 1/1/2011
• Stem Cell Transplantation for Adults and Children with Sickle Cell Disease: Progress at a Different Pace  
  Horwitz, M, The Hematologist, 1/1/2011
• "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previous...  
  Gasparetto C, Gockerman JP, Diehl LF, de Castro CM, Moore JO, Long GD, Horwitz ME, Keogh G, Chute JP, Sullivan KM, Neuwirth R, Davis PH, Sutton LM, Anderson RD, Chao N..., Biol Blood Marrow Transplant, 1/1/2010
• Umbilical Cord Blood Transplantation for Treatment of Non-malignant Disorders  
  Horwitz Mitchell, Chao Nelson, Cellular Therapy and Transplantation, 1/1/2010
• Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors  
  Rizzieri DA, Dev P, Long GD, Gasparetto C, Sullivan KM, Horwitz M, Chute J, Chao NJ, Bone Marrow Transplant, 1/1/2009
• Allogeneic hematopoietic stem cell transplantation for Leukocyte Adhesion Deficiency  
  Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G, Farinha N, Filopovich A, Fischer A, Friedrich W, Gennery A, Heilmann C, Landais P, Horwitz M, Porta F..., Pediatrics, 1/1/2009
• Join now to see all

Books/Book Chapters

• Cord Blood Biology, Transplantation, Banking and Regulation 
  Chapter: Umbilical Cord Blood Transplantation for Treatment of Non-malignant Disorders 
  Horwitz M, Chao NEditors: Broxmeyer H.AABB Press, Bethesda MD2011
• Stem Cell Transplantation for Hematologic and other Disorders 
  Chapter: Umbilical Cord Hematopoietic Stem Cell Transplantation 
  Horwitz Mitchell, Chao NelsonEditors: Soiffer R.Humana Press, Totowa NJ2007
• Blood Reviews 
  Chapter: Chronic Graft versus Host Disease 
  Page 15 - 27Horwitz, Mitchell, Sullivan, Keith2006
• Gene Therapy: Therapeutic Mechanisms and Strategies 
  Chapter: Gene Therapy for Hematopoietic Disorders 
  Horwitz ME, Malech HLEditors: Templeton N.S.Marcel Dekker Inc, New York, NY1999
• Hematology 
  Chapter: Stem Cell Transplantation 
  Horwitz M, Dunbar DEditors: Schiffman F.Lippencott-Raven, Philadelphia, PA1998
• Join now to see all

Abstracts/Posters

• Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host Disease
  Mitchell E. Horwitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Daily Chlorhexidine Gluconate Bathing Reduces the Rate of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Stem Cell Transplantation
  Mitchell E. Horwitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell Transplantation
  Mitchell E. Horwitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...
  Mitchell E. Horwitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd
  Mitchell E. Horwitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation
  Anthony D. Sung, Julia A.M. Sung, Kelly Corbet, Vera Hars, Lan Lan, Gloria Broadwater, Ashley Zanter, John Chute, Cristina Gasparetto, Gwynn Long, David Rizzieri, Keit..., 1/1/2013
• Nicord(R) Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraf...
  Mitchell E. Horwitz, Patrick J. Stiff, Nelson J. Chao, David Rizzieri, Gwynn Long, Keith Sullivan, Cristina Gasparetto, John Chute, Ashley Morris, Carolyn McDonald, St..., Biology of Blood and Marrow Transplant, 1/1/2013
• NiCord(R) expanded Hematopoietic Progenitor Cells (HPC) are Capable of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UC...
  Mitchell E. Horwitz, MD, Nelson J. Chao, MD, David A. Rizzieri, MD, Gwynn D. Long, MD, Keith M. Sullivan, MD, Cristina Gasparetto, MD, John P. Chute, MD, Ashley Morris..., Annual meeting of the American Society of Blood and Marrow Transplantation, San Diego, CA, 1/1/2012
• Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation
  Anthony D. Sung, Julia A.M. Sung, Kelly Corbet, Gloria Broadwater, Vera Hars, Ashley Zanter, Nelson J. Chao, and Mitchell E. Horwitz, Blood (ASH Annual Meeting Abstracts), 1/1/2012
• Use of cyclosporine is associated with the increase in pre-engraftment syndrome after myeloablative dual cord blood transplantation
  Junya Kanda, MD, Leylagul Kaynar, MD, Yoshinobu Kanda, MD, Vinod K. Prasad, MD, Suhag H. Parikh, MD, David A. Rizzieri, MD, Gwynn D. Long, MD, Keith M. Sullivan, MD, C..., Annual meeting of the American Society of Hematology, San Diego, CA, 1/1/2011
• The Impact of Lymphocyte Subset Recovery at 3 Months on Progression-free survival after Myeloablative Allogeneic Stem Cell Transplantation
  Junya Kanda, MD, David A. Rizzieri, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, John P. Chute, MD, Keith M. Sullivan, MD, Ashley Morris, PharmD, Jacalyn McPherson,..., Annual meeting of the American Society of Hematology, San Diego, CA, 1/1/2011
• Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation
  J. Kanda, L. Kaynar, Y. Kanda, V.K. Prasad, S.H. Parikh, D.A. Rizzieri, G.D. Long, K.M. Sullivan, C. Gasparetto, J.P. Chute, A. Morris, S. Winkel, J. McPherson, J. Kur..., Biology of Blood and Marrow Transplant, 1/1/2011
• Polyoma Virus Is The Principal Cause Of Cystitis Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation
  T. Khan, K. Richard, G. Broadwater, S.E. Hemphill, M. Lassiter, M.E. Horwitz, Biology of Blood and Marrow Transplant, 1/1/2010
• Plerixafor Given “Just In Time” For Peripheral Blood Stem Cell Mobilization Of Patients With Suboptimal Response To G-CSF
  M. Horwitz, T. Khan, G. Long, C. Gasparetto, K. Sullivan, J. Chute, D. Rizzieri, S. Drago, N. Chao, Biology of Blood and Marrow Transplant, 1/1/2010
• Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil(R)) + G-CSF In Adult Patients with Non-Hematologic Malignancies
  Mitchell E. Horwitz, Edward Gorak, Peter Holman, Edward Libby, Dirk Huebner, Purvi D Mody, and Jeffrey R. Schriber, Blood (ASH Annual Meeting Abstracts), 1/1/2010
• Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning
  Junya Kanda, David A. Rizzieri, Cristina Gasparetto, Gwynn D. Long, John P. Chute, Keith M. Sullivan, Ashley Morris, Clayton A. Smith, Donna E. Hogge, Janet Nitta, Kev..., Blood (ASH Annual Meeting Abstracts), 1/1/2010
• A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplan...
  Lun-Wei Chiou, Junya Kanda, Paul Szabolcs, Gregory E. Sempowski, Jeffrey Hale, Donna Niedzwiecki, Gloria Broadwater, Nelson J. Chao, and Mitchell E. Horwitz, Blood (ASH Annual Meeting Abstracts), 1/1/2010
• Survival Following Allogeneic Stem Cell Transplantation for Congenital Immunodeficiency and Metabolic Disorders
  M.E. Horwitz, G. Tunes da Silva, M. Eapen, E.M. Horwitz, Biol Blood Marrow Transplant, 1/1/2009
• Total Body Irradiation 1350cGy/Fludarabine (TBI/FLU) vs Myeloablative Busulfan/Fludarabine (Bu/Flu) Preparation in Adult Recipients of Dual Umbilical Cord Blood (UCB) ...
  Mitchell Horwitz, John Chute, Cristina Gasparetto, Gwynn Long, David Rizzieri, Keith Sullivan, Jackie McPherson, and Nelson Chao, Blood (ASH Annual Meeting Abstracts, 1/1/2008
• Fludarabine-based non-myeloablative stem cell transplantation in a patient with sickle cell disease and renal failure
  I. Spasojevic, A. Morris, G. Long, C. Gasparetto, K. Sullivan, J. Chute, M. Telen, N. Chao, D. Rizzieri, M. Horwitz, Biology of Blood and Marrow Transplant, 1/1/2007
• Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients
  Mitchell Horwitz, John Chute, Cristina Gasparetto, Gwynn Long, David Rizzieri, Ashley Morris, Jackie McPherson, Keith Sullivan, and Nelson Chao, Blood (ASH Annual Meeting Abstracts, 1/1/2007
• Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival
  Mitchell Horwitz, David Rizzieri, Gwynn D. Long, Cristina Gasparetto, Ashley Morris, Keith Sullivan, John Chute, Dawn Marshall, and Nelson Chao, Blood (ASH Annual Meeting Abstracts, 1/1/2006
• Join now to see all

Lectures

• Stem Cell Transplant for Bone Marrow Failure Disorders 
  Durham, NC - 1/15/2015
• Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia; Transplant or Not in 1st Complete Remission 
  Asheville, NC - 1/12/2015
• Myelofibrosis; To Transplant or Not? 
  Asheville, NC - 1/11/2015
• Improving the Outcome of UCB Transplantation through Ex Vivo Expansion or Graft Manipulation 
  Clinical Center of the National Institutes of Health, Bethesda, MD - 1/4/2015
• Stem Cell Transplantation for Sickle Cell Disease 
  Raleigh, NC - 1/1/2015
• Research and Progress Session: Stem/Progenitor Cell Expansion and Engraftment 
  1/26/2014
• Adult Umbilical Cord Blood Transplantation; Past, Present and Future 
  University of North Carolina, Chapel Hill, NC - 1/16/2014
• Umbilical Cord Blood Stem Cells Cultured in the Presence of Nicotinamide (NiCord(TM)) Provide Long Term Multi-lineage Engraftment 
  Philadelphia, PA - 1/6/2014
• Adult Umbilical Cord Blood Transplantation; Past, Present and Future Oncology 
  Charlotte, NC - 1/4/2014
• Umbilical Cord Blood Stem Cells Expanded in the Presence of Nicotinamide (NiCord) Provide Long Term Multi-lineage Engraftment 
  Philadelphia, PA - 1/1/2013
• Cord Blood Expansion 
  Alexandria, VA - 1/1/2012
• Current Status of Adult Umbilical Cord Blood Transplantation 
  Duke University Medical Center, Durham, NC - 1/2/2011
• Umbilical Cord Blood Transplantation for Treatment of Adult Patients with Hematologic Malignancies 
  Durham, NC - 1/30/2010
• Transplantation vs. Novel, Less Toxic Approaches to Myelodysplastic Syndrome 
  Asheville, NC - 1/1/2010
• Stem Cell Transplantation for Malignant and Non-Malignant Conditions 
  Eden, NC - 1/1/2008
• Nonmyeloablative Allogeneic Stem Cell Transplantation for Sickle Cell Disease 
  Durham, NC - 1/23/2007
• Clinical Utility of FDG-PET Scanning In Restaging of Lymphoma 
  Hot Springs, VA - 1/1/2005
• Poor Prognosis Non-Hodgkins Lymphoma: How Aggressive to Treat? 
  Asheville, NC - 1/1/2005
• Stem Cell Transplantation for Myelodysplastic Syndrome 
  Asheville, NC - 1/1/2004
• Join now to see all